C. Tanaka

Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy

Larissa J. Lee, Brooke E. Howitt, Paul J. Catalano et al. · Gynecologic Oncology · 2016 · 115 citations

Medicine, Oncology, Radiation Oncology +13

Magnetic resonance–guided interstitial therapy for vaginal recurrence of endometrial cancer

Akila N. Viswanathan, Robert A. Cormack, Caroline L. Holloway et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 98 citations

Medicine, Gynecology, Oncology +7

Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3–4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva

Raymond H. Mak, Lia M. Halasz, C. Tanaka et al. · Gynecologic Oncology · 2010 · 47 citations

Medicine, Oncology, Radiation Oncology +16

A Phase I/II Study of AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, on a Continuous Daily Dosing Schedule in Adult Patients (pts) with Imatinib-Resistant Advanced Phase Chronic Myeloid Leukemia (CML) or Relapsed/Refractory Philadelphia Chromosome (Ph+) Acute Llymphocytic Leukemia (ALL).

Francis J. Giles, Hagop M. Kantarjian, Jörge E. Cortes et al. · Blood · 2004 · 33 citations

Medicine, Oncology, Pharmacology +12

A phase I study of AMN107 alone and in combination with imatinib in patients (pts) with imatinib-resistant gastrointestinal stromal tumors (GIST)

Peter Reichardt, Paolo G. Casali, Jean‐Yves Blay et al. · Journal of Clinical Oncology · 2006 · 11 citations

Medicine, Oncology, Pharmacology +12